- Home
- AMBQ vs CATX Comparison
AMBQ vs CATX Comparison
Compare AMBQ & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMBQ | CATX |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 594.9M | 497.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | AMBQ | CATX |
|---|---|---|
| Price | $34.88 | $4.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $41.75 | $12.11 |
| AVG Volume (30 Days) | 304.4K | ★ 966.3K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.81 | N/A |
| Revenue Next Year | $27.98 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.12 | $1.93 |
| 52 Week High | $43.06 | $6.16 |
Technical Indicators
Market Signals| Indicator | AMBQ | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 73.02 | 54.93 |
| Support Level | $34.50 | $3.17 |
| Resistance Level | $34.82 | $5.86 |
| Average True Range (ATR) | 1.58 | 0.28 |
| MACD | 0.94 | 0.03 |
| Stochastic Oscillator | 91.40 | 87.90 |
Price Performance
Historical ComparisonAbout AMBQ Ambiq Micro Inc.
Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.